We are live on
!
Find out more
Gilead Sciences
GILD
GILD
2,308 hedge funds and large institutions have $148B invested in Gilead Sciences in 2026 Q1 according to their latest regulatory filings, with 245 funds opening new positions, 852 increasing their positions, 891 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 245 | Existing positions closed: 105
72% more call options, than puts
Call options by funds: $1.38B | Put options by funds: $804M
14% more funds holding in top 10
Funds holding in top 10: 28 → 32 (+4)
10% more capital invested
Capital invested by funds: $134B → $148B (+$13.9B)
4% more funds holding
Funds holding: 2,213 → 2,308 (+95)
4% less repeat investments, than reductions
Existing positions increased: 852 | Existing positions reduced: 891
2.49% less ownership
Funds ownership: 88.04% → 85.55% (-2.5%)
Holders
2,308
Holders Change
+95
Holders Change %
+4.29%
% of All Funds
28.43%
Holding in Top 10
32
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+14.29%
% of All Funds
0.39%
New
245
Increased
852
Reduced
891
Closed
105
Calls
$1.38B
Puts
$804M
Net Calls
+$577M
Net Calls Change
+$513M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$1.53B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$886M |
| 3 |
Goldman Sachs
New York
|
+$324M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$288M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$255M |
